慢性腎臓病の世界市場レポート 2024

慢性腎臓病の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には5.9%の年間複合成長率（CAGR）で882億6,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、重点的なヘルスケア政策、精密医療の発展、肥満率の増加、慢性疾患の増加、ヘルスケアアクセスの改善に起因すると考えられます。予測期間の主な動向には、早期スクリーニングを促進するキャンペーン、遠隔医療と遠隔モニタリングの統合、患者に力を与えるプログラム、地域ベースのケアへの取り組み、栄養療法の統合などが含まれます。これらの動向は集合的に、慢性腎臓病の管理とケアの進化する情勢に貢献しています。

腎臓病の有病率の拡大により、慢性腎臓病（CKD）市場の拡大が見込まれています。腎臓病には、腎臓の機能と構造に影響を与えるさまざまな状態が含まれており、多くの場合、症状を管理し、血圧を制御し、タンパク質の損失を最小限に抑えるために投薬が必要になります。2022年7月の疾病管理予防センターのデータによると、米国の約15%または3,700万人が腎臓病に苦しんでおり、その有病率の急増が浮き彫りになっています。したがって、この普及率の高まりは、慢性腎臓病市場の成長軌道を推進する重要な推進力となります。

高齢化人口の急増は、慢性腎臓病市場の拡大に大きく寄与すると予想されます。「高齢化人口」という用語は、社会または人口内での高齢者の割合の増加によって特徴づけられる人口動態の傾向を指します。この人口動態の変化は、高齢者における腎臓関連の問題の発生率の増加による慢性腎臓病（CKD）管理への依存度の上昇と密接に関連しています。年齢とともに、CKDを含む腎臓病のリスクは増加する傾向があります。注目すべきことに、世界保健機関の2022年10月の報告書は、60歳以上の世界人口が2050年までに倍増し、推定21億人に達すると予想される急速な増加予測を強調しています。したがって、高齢化人口の増加は、慢性腎臓病市場の成長軌道を推進する重要な要因です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の慢性腎臓病市場、診断別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 血液検査
• 尿検査
• 画像検査
• 腎生検
• 世界の慢性腎臓病市場、治療別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 薬剤
• 透析
• 腎臓移植
• ACE阻害剤
• 血液検査
• その他の治療
• 世界の慢性腎臓病市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 経口
• 静脈内
• 皮下
• 世界の慢性腎臓病市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院とクリニック
• 外来手術センター（ASC）
• 透析センター
• その他のエンドユーザー

第7章 地域および国の分析

• 世界の慢性腎臓病市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界の慢性腎臓病市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 慢性腎臓病市場の競合情勢
• 慢性腎臓病市場の企業プロファイル
  • Pfizer Inc
  • Johnson and Johnson Services Inc.
  • F. Hoffmann-La Roche Ltd.
  • AbbVie Inc.
  • Bayer AG

第31章 その他の大手および革新的な企業

• Novartis International AG
• Sanofi SA
• Bristol-Myers Squibb Company
• Abbott laboratories Inc.
• GlaxoSmithKline PLC
• Takeda Pharmaceuticals Ltd.
• Eli Lilly and Company
• Boehringer Ingelheim International GmbH
• Amgen Inc.
• Novo Nordisk AS
• Siemens Healthineers AG
• AstraZeneca Pharmaceuticals LP
• Teva Pharmaceutical Industries Ltd.
• Beckman Coulter Inc.
• Kissei Pharmaceutical Co. Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Chronic kidney disease is characterized by impaired kidney function, leading to the inefficient filtration of blood, resulting in the accumulation of excess fluid and waste in the body. Common causes include diabetes, high blood pressure, and obesity. Managing this condition requires ongoing care and may progress to end-stage renal failure, necessitating dialysis or transplantation.

Key diagnostic tests for chronic kidney disease include blood tests, urine tests, imaging tests, and kidney biopsy. Blood tests involve the examination of a blood sample for medical evaluation. Treatment modalities encompass drugs, dialysis, kidney transplants, ACE inhibitors, and other interventions. These drugs can be administered through oral, intravenous, and subcutaneous routes, catering to various end-users such as hospitals, clinics, ambulatory surgery centers (ASCS), dialysis centers, and others.

The chronic kidney disease market research report is one of a series of new reports from The Business Research Company that provides chronic kidney disease market statistics, including the chronic kidney disease industry global market size, regional shares, competitors with a chronic kidney disease market share, detailed chronic kidney disease market segments, market trends, and opportunities, and any further data you may need to thrive in the chronic kidney disease industry. This chronic kidney disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The chronic kidney disease market size has grown strongly in recent years. It will grow from $65.74 billion in 2023 to $70.2 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth observed in the historical period can be attributed to several factors, including the prevalence of the hypertension and diabetes epidemic, an aging population, unhealthy lifestyles, disparities in healthcare access, and advancements in medical technologies. These factors collectively contributed to the increased incidence and awareness of chronic kidney disease during that period.

The chronic kidney disease market size is expected to see strong growth in the next few years. It will grow to $88.26 billion in 2028 at a compound annual growth rate (CAGR) of 5.9%. The anticipated growth in the forecast period can be attributed to a focused healthcare policy, the development of precision medicine, an increase in obesity rates, the growth of chronic diseases, and improvements in healthcare access. Key trends in the forecast period include campaigns promoting early screening, the integration of telemedicine and remote monitoring, programs empowering patients, initiatives for community-based care, and the integration of nutritional therapy. These trends collectively contribute to the evolving landscape of chronic kidney disease management and care.

The escalating prevalence of kidney disease is poised to drive the expansion of the chronic kidney disease (CKD) market. Kidney diseases encompass various conditions that affect the kidneys' function and structure, often necessitating medication to manage symptoms, control blood pressure, and minimize protein loss. As per data from the Centers for Disease Control and Prevention in July 2022, approximately 15% or 37 million individuals in the US grapple with kidney disease, underscoring the surge in its prevalence. Consequently, this mounting prevalence is a key driver propelling the growth trajectory of the chronic kidney disease market.

The burgeoning aging population is anticipated to contribute significantly to the chronic kidney disease market's expansion. The term 'aging population' denotes a demographic trend marked by a higher proportion of elderly individuals within a society or populace. This demographic shift is closely associated with an elevated reliance on chronic kidney disease (CKD) management due to the rising incidence of kidney-related issues among the elderly. With age, the risk of kidney ailments, including CKD, tends to escalate. Notably, the World Health Organization's October 2022 report highlights a rapid growth projection for the global population aged 60 years and older, expected to double by 2050, reaching an estimated 2.1 billion individuals. Hence, the increasing aging demographic is a significant factor propelling the chronic kidney disease market's growth trajectory.

Product innovation stands out as a pivotal trend gaining momentum in the chronic kidney disease market. Companies navigating this sector are dedicating efforts toward developing innovative products to fortify their market presence. For example, Bayer, a Germany-based biotechnology and pharmaceutical entity, unveiled Kerendia (finerenone) in August 2022. This groundbreaking medicine, categorized as a non-steroidal, selective mineralocorticoid receptor antagonist, offers a novel approach to decelerate chronic kidney disease progression among diabetic patients. Its distinctive mechanism involves the blocking of mineralocorticoid receptor (MR) overactivation, thereby addressing factors contributing to CKD progression and associated cardiovascular damage, setting it apart from existing treatments.

Major players in the chronic kidney disease market are engaging in strategic partnerships to explore the safety and efficacy of an enhanced Automated Wearable Artificial Kidney Peritoneal Dialysis (AWAK PD) device. These strategic partnerships involve collaborations where companies harness each other's strengths and resources to achieve mutual benefits. As an illustration, in June 2023, AWAK Technologies Pte Ltd., a Singapore-based medical technology firm, forged a partnership with Singapore General Hospital Pte Ltd. (SGH), an academic health science center and hospital entity in Singapore. This collaboration aims to revolutionize kidney disease diagnosis, treatment, and management by spearheading the development and evaluation of AWAK PD, a wearable and ultra-portable peritoneal dialysis (PD) system. This innovative system allows end-stage kidney disease patients the flexibility to undergo dialysis at home and while on the move, thereby enhancing their quality of life and treatment convenience.

In January 2023, the US-based biopharmaceutical company AstraZeneca Pharmaceuticals LP successfully acquired CinCor Pharma Inc. for $1.8 billion. Through this acquisition, AstraZeneca aims to enrich its cardiorenal pipeline by incorporating CinCor's candidate medicine, baxdrostat (CIN-107). Baxdrostat is an aldosterone synthase inhibitor (ASI) designed for blood pressure control in the treatment of resistant hypertension. CinCor Pharma Inc., based in the US, is a clinical-stage biopharmaceutical company specializing in the development of products for the treatment of resistant and uncontrolled hypertension, as well as chronic kidney disease.

Major companies operating in the chronic kidney disease market report are Pfizer Inc., Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott laboratories Inc., GlaxoSmithKline PLC, Takeda Pharmaceuticals Ltd., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk AS, Siemens Healthineers AG, AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Beckman Coulter Inc., Kissei Pharmaceutical Co. Ltd., Akebia Therapeutics Inc., Mission Therapeutics Ltd., Tricida Inc., Regulus Therapeutics Inc., Goldfinch Bio Co, Alio Inc., Monogram Health, Strive Health, Maze Therapeutics, ProKidney Corp

North America was the largest region in the chronic kidney disease market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the chronic kidney disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chronic kidney disease market consists of revenues earned by entities by providing peritoneal dialysis, in-center hemodialysis, and home hemodialysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic kidney disease market also includes sales such as captopril, enalapril, finerenone, and fosinopril used during the treatment procedure. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chronic Kidney Disease Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chronic kidney disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chronic kidney disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chronic kidney disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Diagnosis: Blood Test; Urine Test; Imaging Test; Kidney Biopsy
• 2) By Treatment: Drugs; Dialysis; Kidney Transplant; ACE Inhibitors; Blood Test; Other Treatments
• 3) By Route of Administration: Oral; Intravenous; Subcutaneous
• 4) By End-User: Hospital And Clinics; Ambulatory Surgery Centers (ASCs); Dialysis Centers; Other End-Users
• Companies Mentioned: Pfizer Inc; Johnson and Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Chronic Kidney Disease Market Characteristics

3. Chronic Kidney Disease Market Trends And Strategies

4. Chronic Kidney Disease Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Chronic Kidney Disease Market Size and Growth

• 5.1. Global Chronic Kidney Disease Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Chronic Kidney Disease Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Chronic Kidney Disease Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Chronic Kidney Disease Market Segmentation

• 6.1. Global Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Blood Test
• Urine Test
• Imaging Test
• Kidney Biopsy
• 6.2. Global Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Drugs
• Dialysis
• Kidney Transplant
• ACE Inhibitors
• Blood Test
• Other Treatments
• 6.3. Global Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral
• Intravenous
• Subcutaneous
• 6.4. Global Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital And Clinics
• Ambulatory Surgery Centers (ASCs)
• Dialysis Centers
• Other End-Users

7. Chronic Kidney Disease Market Regional And Country Analysis

• 7.1. Global Chronic Kidney Disease Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Chronic Kidney Disease Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Chronic Kidney Disease Market

• 8.1. Asia-Pacific Chronic Kidney Disease Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Chronic Kidney Disease Market

• 9.1. China Chronic Kidney Disease Market Overview
• 9.2. China Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Chronic Kidney Disease Market

• 10.1. India Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Chronic Kidney Disease Market

• 11.1. Japan Chronic Kidney Disease Market Overview
• 11.2. Japan Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Chronic Kidney Disease Market

• 12.1. Australia Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Chronic Kidney Disease Market

• 13.1. Indonesia Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Chronic Kidney Disease Market

• 14.1. South Korea Chronic Kidney Disease Market Overview
• 14.2. South Korea Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Chronic Kidney Disease Market

• 15.1. Western Europe Chronic Kidney Disease Market Overview
• 15.2. Western Europe Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Chronic Kidney Disease Market

• 16.1. UK Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Chronic Kidney Disease Market

• 17.1. Germany Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Chronic Kidney Disease Market

• 18.1. France Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Chronic Kidney Disease Market

• 19.1. Italy Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Chronic Kidney Disease Market

• 20.1. Spain Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Chronic Kidney Disease Market

• 21.1. Eastern Europe Chronic Kidney Disease Market Overview
• 21.2. Eastern Europe Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Chronic Kidney Disease Market

• 22.1. Russia Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Chronic Kidney Disease Market

• 23.1. North America Chronic Kidney Disease Market Overview
• 23.2. North America Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Chronic Kidney Disease Market

• 24.1. USA Chronic Kidney Disease Market Overview
• 24.2. USA Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Chronic Kidney Disease Market

• 25.1. Canada Chronic Kidney Disease Market Overview
• 25.2. Canada Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Chronic Kidney Disease Market

• 26.1. South America Chronic Kidney Disease Market Overview
• 26.2. South America Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Chronic Kidney Disease Market

• 27.1. Brazil Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Chronic Kidney Disease Market

• 28.1. Middle East Chronic Kidney Disease Market Overview
• 28.2. Middle East Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Chronic Kidney Disease Market

• 29.1. Africa Chronic Kidney Disease Market Overview
• 29.2. Africa Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Chronic Kidney Disease Market Competitive Landscape And Company Profiles

• 30.1. Chronic Kidney Disease Market Competitive Landscape
• 30.2. Chronic Kidney Disease Market Company Profiles
  • 30.2.1. Pfizer Inc
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Johnson and Johnson Services Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. F. Hoffmann-La Roche Ltd.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. AbbVie Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Bayer AG
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Chronic Kidney Disease Market Other Major And Innovative Companies

• 31.1. Novartis International AG
• 31.2. Sanofi SA
• 31.3. Bristol-Myers Squibb Company
• 31.4. Abbott laboratories Inc.
• 31.5. GlaxoSmithKline PLC
• 31.6. Takeda Pharmaceuticals Ltd.
• 31.7. Eli Lilly and Company
• 31.8. Boehringer Ingelheim International GmbH
• 31.9. Amgen Inc.
• 31.10. Novo Nordisk AS
• 31.11. Siemens Healthineers AG
• 31.12. AstraZeneca Pharmaceuticals LP
• 31.13. Teva Pharmaceutical Industries Ltd.
• 31.14. Beckman Coulter Inc.
• 31.15. Kissei Pharmaceutical Co. Ltd.

32. Global Chronic Kidney Disease Market Competitive Benchmarking

33. Global Chronic Kidney Disease Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Chronic Kidney Disease Market

35. Chronic Kidney Disease Market Future Outlook and Potential Analysis

• 35.1 Chronic Kidney Disease Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Chronic Kidney Disease Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Chronic Kidney Disease Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer